HomeRitonavirRitonavir + Lamivudine And Tenofovir Disoproxil Fumarate

Does Ritonavir Interact with Lamivudine And Tenofovir Disoproxil Fumarate?

Ritonavir and Lamivudine And Tenofovir Disoproxil Fumarate have a moderate drug interaction according to U.S. FDA drug labeling data. 7 DRUG INTERACTIONS • Atazanavir: Atazanavir should be coadministered with ritonavir when coadministered with CIMDUO. ( 7.2 ) • HIV-1 Protease Inhibitors: Monitor for evidence of tenofovir toxicity when CIMDUO is coadministrated with atazanavir/ritonavir, darunavir/ritonavir, or lopinavir/ritonavir. When coadministered with CIMDUO, it is recommended that atazanavir 300 mg is given with ritonavir 100 mg. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Ritonavir Class
Cytochrome P450 3A Inhibitor
Lamivudine And Tenofovir Disoproxil Fumarate Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Ritonavir and your doctor is considering prescribing Lamivudine And Tenofovir Disoproxil Fumarate (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Ritonavir(Norvir)+💊 Lamivudine And Tenofovir Disoproxil Fumarate(Cimduo)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Cytochrome P450 3A Inhibitor
Drug B class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Source
FDA drug label - lamivudine and tenofovir disoproxil fumarate

What this means in plain English

7 DRUG INTERACTIONS • Atazanavir: Atazanavir should be coadministered with ritonavir when coadministered with CIMDUO. ( 7.2 ) • HIV-1 Protease Inhibitors: Monitor for evidence of tenofovir toxicity when CIMDUO is coadministrated with atazanavir/ritonavir, darunavir/ritonavir, or lopinavir/ritonavir. When coadministered with CIMDUO, it is recommended that atazanavir 300 mg is given with ritonavir 100 mg.

About Ritonavir and Lamivudine And Tenofovir Disoproxil Fumarate

Ritonavir is a Cytochrome P450 3A Inhibitor, while Lamivudine And Tenofovir Disoproxil Fumarate is a Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor. You may recognize them by the brand names Norvir and Cimduo. Both medications are taken by mouth. Both Ritonavir and Lamivudine And Tenofovir Disoproxil Fumarate carry an FDA boxed warning — the agency's most serious safety designation.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Ritonavir and Lamivudine And Tenofovir Disoproxil Fumarate against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.